Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
Adaptimmune Therapeutics PLC (ADAP) had Current Liabilities of $51.51M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$13.68M |
|
$-30.34M |
|
$2.50M |
|
$11.18M |
|
$43.97M |
|
$-30.29M |
|
$0.56M |
|
$-29.73M |
|
$-29.73M |
|
$-30.34M |
|
$-30.34M |
|
$-30.34M |
|
$-30.34M |
|
$-30.29M |
|
$-27.78M |
|
264.09M |
|
264.09M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$78.11M |
|
$28.15M |
|
$52.52M |
|
$130.63M |
|
|
Current Liabilities |
$51.51M |
$25.68M |
|
$150.08M |
|
$201.59M |
|
$-70.96M |
|
$-74.77M |
|
$-70.96M |
|
265.05M |
|
| Cash Flow Statement Financials | |
$-101.37M |
|
$59.64M |
|
$-23.67M |
|
$93.21M |
|
$27.78M |
|
$-65.43M |
|
$1.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.52 |
|
-- |
|
-- |
|
-0.57 |
|
-0.36 |
|
81.71% |
|
-221.45% |
|
-221.45% |
|
-- |
|
-217.36% |
|
-221.83% |
|
$-102.65M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.22 |
|
1.47 |
|
61.28 |
|
42.76% |
|
40.58% |
|
-23.23% |
|
67.00% |
|
$-0.27 |
|
$-0.39 |
|
$-0.38 |
|